- Filed
- Jan 14, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Dec 31, 2024 | 1.23B sh |
| Cash And Equivalents | Q2 2025 · Nov 30, 2024 | $21.34M |
| Cash And Equivalents | Q2 2025 · May 31, 2024 | $3.11M |
| Cash And Equivalents | Q2 2025 · Nov 30, 2023 | $147K |
| Current Liabilities | Q2 2025 · Nov 30, 2024 | $70.63M |
| Current Liabilities | Q2 2025 · May 31, 2024 | $84.18M |
| Total Liabilities | Q2 2025 · Nov 30, 2024 | $114.27M |
| Total Liabilities | Q2 2025 · May 31, 2024 | $127.89M |
| Current Assets | Q2 2025 · Nov 30, 2024 | $24.63M |
| Current Assets | Q2 2025 · May 31, 2024 | $10.82M |
| Total Assets | Q2 2025 · Nov 30, 2024 | $24.88M |
| Total Assets | Q2 2025 · May 31, 2024 | $11.14M |
| Shares Diluted | Q2 2025 · Nov 30, 2023 | 958.99M sh |
| Shares Diluted | Q2 2025 · Nov 30, 2023 | 941.19M sh |
| Operating Cash Flow | Q2 2025 · Nov 30, 2023 | −$7M |
| Stockholders Equity | Q2 2025 · Nov 30, 2023 | −$114.38M |
| Stockholders Equity | Q2 2025 · Aug 31, 2023 | −$116.89M |
| Stockholders Equity | Q2 2025 · May 31, 2023 | −$109.5M |
| Eps Diluted | Q2 2025 · Nov 30, 2023 | −$0.01 |
| Eps Diluted | Q2 2025 · Nov 30, 2023 | −$0.02 |
| Eps Basic | Q2 2025 · Nov 30, 2023 | −$0.01 |
| Eps Basic | Q2 2025 · Nov 30, 2023 | −$0.02 |
| Sga Expense | Q2 2025 · Nov 30, 2023 | $2.31M |
| Sga Expense | Q2 2025 · Nov 30, 2023 | $5M |
| Net Income | Q2 2025 · Nov 30, 2023 | −$9.56M |
| Net Income | Q2 2025 · Nov 30, 2023 | −$21.13M |
| Net Income | Q2 2025 · Aug 31, 2023 | −$11.57M |
| Operating Income | Q2 2025 · Nov 30, 2023 | −$3.4M |
| Operating Income | Q2 2025 · Nov 30, 2023 | −$8.01M |